Novartis India reports net loss at Rs 71 lakh in Q3 Ruchika Sharma14 Feb 2021 9:00 AM ISTNew Delhi: Drug firm Novartis India on Thursday reported a net loss of Rs 71 lakh for the quarter ended December 31, 2020.The company had posted...
Novartis gets USFDA Breakthrough Therapy designations for STAMP inhibitor asciminib to treat chronic myeloid leukemia Ruchika Sharma9 Feb 2021 11:00 AM ISTAsciminib (ABL001) is an investigational treatment specifically targeting the ABL myristoyl pocket (STAMP).
Novartis to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine production Ruchika Sharma1 Feb 2021 12:33 PM ISTBasel: Pharma major, Novartis, has recently announced that the company has signed an initial agreement to leverage its manufacturing capacity and...
Covid-19: Novartis in discussion with firms for manufacturing vaccines, tests Ruchika Sharma30 Jan 2021 9:00 AM ISTZurich: Novartis is talking to other companies about helping to make vaccines and tests for COVID-19, the Swiss drugmaker said on Thursday without...
Novartis Committed to Sandoz generic business: CEO Vas Narasimhan Ruchika Sharma27 Jan 2021 12:37 PM ISTZurich: Novartis Chief Executive Vas Narasimhan on Tuesday renewed his commitment to his Sandoz generic unit where sales growth in 2020 stagnated due...
Novartis inclisiran gets complete USFDA response letter for treating hyperlipidemia Ruchika Sharma21 Dec 2020 1:01 PM ISTThe FDA stated that the agency cannot approve the NDA by the Prescription Drug User Fee Act(PDUFA) action date of December 23, 2020, due to unresolved...
Novartis, Mesoblast ink deal worth Rs 370 crore for Remestemcel-L for Covid ARDS Ruchika Sharma22 Nov 2020 10:30 AM ISTZurich: Novartis aims to boost its respiratory treatment portfolio with a $50 million deal for an off-the-shelf cell therapy from Mesoblast that it...
Setback: Novartis arthritis drug Canakinumab fails to help Covid patients Ruchika Sharma8 Nov 2020 11:00 AM ISTZurich: Novartis's canakinumab failed to help Covid-19 patients survive without invasive ventilation compared with standard therapy, the Swiss...
Intellectual Property Apellate Board stays cancellation of Novartis patent for Anti-Cancer Drug Ceritinib Farhat Nasim5 Oct 2020 3:33 PM ISTNew Delhi: The Intellectual Property Apellate Board (IPAB) has recently stayed the cancellation of the Swiss drugmaker Novartis' patent over the...
BioNTech acquires Novartis site to boost COVID vaccine production Ruchika Sharma18 Sept 2020 12:11 PM ISTThe facility in Marburg will be converted to be fully on stream in the first half of 2021 with an annual production capacity up to 750 million doses...
Novartis Enerzair Breezhaler shows positive results in reducing asthma Ruchika Sharma9 Sept 2020 1:39 PM ISTBasel: Novartis has recently announced that high-dose, once-daily Enerzair Breezhaler (indacaterol acetate, glycopyrronium bromide and mometasone...
Novartis push to expand cancer arsenal gets trial win against Pfizer Bosulif Ruchika Sharma28 Aug 2020 9:30 AM ISTZurich: Novartis drug candidate asciminib notched a trial win against Pfizer's Bosulif, the Swiss drugmaker said on Wednesday, as it pushes to expand...
